(2S,4R)-1-((S)-2-(tert-butyl)-20-(4-(((2-fluoro-3-((4-methyl-2-oxo-7-(pyrimidin-2-yloxy)-2H-chromen-3-yl)methyl)phenyl)amino)methyl)-1H-1,2,3-triazol-1-yl)-6,9,12,15,18-pentaoxa-3-azaicosanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide

ID: ALA5277498

Chembl Id: CHEMBL5277498

Max Phase: Preclinical

Molecular Formula: C59H73FN10O11S

Molecular Weight: 1149.36

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NCCOCCOCCOCCOCCOCCn2cc(CNc3cccc(Cc4c(C)c5ccc(Oc6ncccn6)cc5oc4=O)c3F)nn2)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C59H73FN10O11S/c1-38-47-16-15-46(80-58-62-17-8-18-63-58)33-51(47)81-57(74)48(38)31-43-9-7-10-49(52(43)60)64-34-44-35-69(68-67-44)20-22-76-24-26-78-28-30-79-29-27-77-25-23-75-21-19-61-54(59(4,5)6)56(73)70-36-45(71)32-50(70)55(72)66-39(2)41-11-13-42(14-12-41)53-40(3)65-37-82-53/h7-18,33,35,37,39,45,50,54,61,64,71H,19-32,34,36H2,1-6H3,(H,66,72)/t39-,45+,50-,54+/m0/s1

Standard InChI Key:  IXAOVDSCUZVPLD-FANAHGLFSA-N

Alternative Forms

  1. Parent:

    ALA5277498

    ---

Associated Targets(Human)

MAP2K2 Tclin VHL-MAP2K1/MAP2K2 (64 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1149.36Molecular Weight (Monoisotopic): 1148.5165AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wang C, Wang H, Zheng C, Li B, Liu Z, Zhang L, Yuan L, Xu P..  (2023)  Discovery of Coumarin-Based MEK1/2 PROTAC Effective in Human Cancer Cells.,  14  (1.0): [PMID:36655129] [10.1021/acsmedchemlett.2c00446]

Source